[Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].
Radioimmunotherapy in indolent NHL is a new and promising therapy which adds a new therapeutic tool to the treatment palette. Recent advantages in RIT are described and perspectives discussed.